Skip to main content
. Author manuscript; available in PMC: 2019 Jul 25.
Published in final edited form as: Biochem J. 2019 Feb 28;476(4):747–758. doi: 10.1042/BCJ20180848

Figure 1.

Figure 1.

FDA-approved platinum drugs and their DNA intrastrand GpG cross-link adducts. Chloride and dicarboxylate moieties of platinum-based drugs are replaced by water molecules to form reactive aquated platinum species, which preferentially attack the two N7 atoms of adjacent purines. Cisplatin and carboplatin produce the identical (NH3)2Pt-GG adducts, whereas oxaliplatin produces [1,2-cyclohexanediamine]-Pt-GG adducts.